Invention Grant
- Patent Title: Humanized antibodies that recognize alpha-synuclein
-
Application No.: US15387580Application Date: 2016-12-21
-
Publication No.: US09884906B2Publication Date: 2018-02-06
- Inventor: Jose William Saldanha , Tarlochan S. Nijjar
- Applicant: PROTHENA BIOSCIENCES LIMITED
- Applicant Address: IE Co. Dublin
- Assignee: PROTHENA BIOSCIENCES LIMITED
- Current Assignee: PROTHENA BIOSCIENCES LIMITED
- Current Assignee Address: IE Co. Dublin
- Agency: Alston & Bird LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/18 ; G01N33/68
Abstract:
The present application discloses humanized 9E4 antibodies. The antibodies bind to human alpha synuclein and can be used for immunotherapy of Lewy body disease.
Public/Granted literature
- US20170240621A1 Humanized Antibodies That Recognize Alpha-Synuclein Public/Granted day:2017-08-24
Information query
